FIELD: medicine.
SUBSTANCE: present invention refers to medicine, namely to therapy, and concerns treatment of auricular anesthesia by cranial nerves. That is ensured by administering an effective amount of a pharmaceutical composition containing at least one anesthetic and one analgesic into the patient's ear canal. Analgesic is present in the pharmaceutical composition in concentration of 50 to 55 mg per ml, and the anesthetic is in concentration of 2 to 15 mg per ml.
EFFECT: method provides symptomatic treatment of diseases by local auricular anesthesia and blocking the transmission of afferent and efferent signals transmitted through 5, 7, 9, 10, 11 and 12 cranial nerves.
15 cl, 7 tbl, 10 ex, 19 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING DISLUCTION WITH AURICULAR ANESTHESIA OF SKULL NERVE | 2014 |
|
RU2687249C2 |
| METHOD FOR IMPROVING THE HEALTH OF A PATIENT USING OSTEOPATHIC TECHNIQUES ON THE EXTRACRANIAL ENDINGS OF THE MENINGEAL AFFERENTS OF THE CRANIAL NERVES | 2021 |
|
RU2794636C1 |
| METHOD OF TREATING PANCREATIC DISORDERS BY NERVE STIMULATION APPARATUS | 2006 |
|
RU2491104C2 |
| SYSTEMS AND METHODS FOR STIMULATION OF NEURONAL ACTIVITY | 2010 |
|
RU2558459C2 |
| METHODS FOR REDUCING PAIN AND DRUG DELIVERY DEVICES | 2009 |
|
RU2513219C2 |
| METHOD FOR TREATING SUBJECTIVE EAR NOISE BY AURICULAR PERCUTANEOUS ELECTRICAL STIMULATION OF VAGUS NERVE | 2021 |
|
RU2767700C1 |
| DEVICE FOR DELIVERING A MEDICAMENT TO A PATIENT AND METHOD FOR AMELIORATING PAIN ASSOCIATED WITH HEAD AND/OR FACIAL PAIN | 2011 |
|
RU2589645C2 |
| METHOD FOR TREATMENT OF PATIENTS WITH GLOSSODYNIA | 0 |
|
SU1745248A1 |
| APPLICATION OF EPIDERMAL GROWTH FACTOR FOR MORPHOFUNCTIONAL RECOVERY OF PERIPHERAL NERVES IN DIABETIC NEUROPATHY | 2007 |
|
RU2460536C2 |
| NEW THERAPEUTIC COMBINATIONS OF MIRTAZAPINE APPLICABLE IN PAIN CONDITIONS | 2013 |
|
RU2509560C1 |
